BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1669600)

  • 1. The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.
    Horváth M; Mezey Z; Jósfay A; Nánay I; Varsányi M; Geró S
    J Investig Allergol Clin Immunol; 1991 Dec; 1(6):404-10. PubMed ID: 1669600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.
    Horváth M; Varsányl M; Jovanovich N; Romics L; Gerö S
    Allergol Immunopathol (Madr); 1990; 18(2):95-9. PubMed ID: 2371944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and complexed anti-lipoprotein antibodies in vascular diseases.
    Szondy E; Horváth M; Mezey Z; Székely J; Lengyel E; Füst G; Gerö S
    Atherosclerosis; 1983 Oct; 49(1):69-77. PubMed ID: 6651914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated and humoral immune response in various vascular diseases.
    Horváth M; Onody C; Gerö S
    Allergol Immunopathol (Madr); 1980; 8(2):81-6. PubMed ID: 7457288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of immune reactions in cardiac damage during acute myocardial infarction: role of cell-mediated immune response.
    Dimitrijevic M; Vasiljevic Z; Vuckovic-Dekic L; Spasic S
    Panminerva Med; 1997 Jun; 39(2):85-94. PubMed ID: 9230616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dynamics of the immune system indices in myocardial infarct patients].
    Zaremba EF; Terletskaia LM; Savkiv BT; Kiiak IuG; Pan'kovskiĭ VB; Chizh VD; Kushch IO
    Vrach Delo; 1990 Nov; (11):27-9. PubMed ID: 2098976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
    Atchley DH; Lopes-Virella MF; Zheng D; Kenny D; Virella G
    Diabetologia; 2002 Nov; 45(11):1562-71. PubMed ID: 12436340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunological indices of patients who have had a myocardial infarct].
    Sledzevskaia IK; Dubrovskaia GV; Babov KD; Kornilina EM; Shcherbak IaIu
    Vrach Delo; 1990 Jul; (7):26-8. PubMed ID: 2238590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various mechanisms of immune homeostasis in myocardial infarction].
    Dobrotina NA; Kopytova TV; Berezina MA
    Vopr Med Khim; 1988; 34(6):53-7. PubMed ID: 3149073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of immune complexes in myocardial infarct].
    Korochkin EM; Chukaeva II; Litvinova SN; Klebanov GI; Kreĭnina MV; Cherniak VIa
    Sov Med; 1990; (4):7-11. PubMed ID: 2374978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of autoimmune lipoprotein--antibody complex in human plasma and aortic wall].
    Klimov AN; Denisenko AD; Zubzhitskiĭ IuN; Gerchikova EA
    Vopr Med Khim; 1978; 24(4):539-43. PubMed ID: 210589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the seeming and real atherogenicity of LDLP-IgG immune complexes in blood plasma and the arterial wall].
    Klimov AN; Denisenko AD
    Vestn Ross Akad Med Nauk; 2007; (7):3-6. PubMed ID: 17722293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
    Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
    Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response against modified low-density lipoproteins in patients with non-insulin-dependent diabetes mellitus].
    González M; Rojas N; Durán D; Schade A; Campos R; Milos C
    Rev Med Chil; 1997 Aug; 125(8):879-85. PubMed ID: 9567390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.